Miniature laser technology could bring lab testing into your home

By studying how various biomolecules interact with each other – for example antibodies in the immune system and xenobiotic antigens – researchers can gain valuable insights leading to new medicines and vaccines or assess whether a sample contains signs of infection

Centauri Therapeutics granted FDA QIDP status for CTX-187 treatment of Gram-negative bacterial infections

Dr. Debra Barker, Chief Medical Officer, Centauri Therapeutics, said: “This designation from the FDA will be invaluable as we continue to advance toward first in-human trials for CTX-187. The recognition of the potential value of our technology further underpins our belief in its potential to transform treatment paradigms for Gram-negative bacterial infections, filling an urgently needed gap in the market for new and effective treatment options for clinically vulnerable patients.”

Stryker launches SmartHospital Platform

Stryker, SmartHospital Platform

“We are dedicated to partnering with our customers on their digital journeys to help elevate care delivery,” said Scott Sagehorn, VP/GM of Smart Care at Stryker. “The SmartHospital Platform is designed to evolve alongside health systems so teams can work more efficiently and stay focused on patient-centered care.”